Testicular germ cell tumours (TGCTs) are the most common solid malignancy among young men, and their incidence is still increasing. Despite good curability with cisplatin (CDDP)-based chemotherapy, about 10% of TGCTs are non-responsive and show a chemoresistant phenotype. To further increase TGCT curability, better prediction of risk of relapse and early detection of refractory cases is needed. Therefore, to diagnose this malignancy more precisely, stratify patients more accurately and improve decision-making on treatment modality, new biomarkers are still required. Numerous studies showed association of differential expressions of microRNAs (miRNAs) with cancer. Using microarray analysis followed by RT-qPCR validation, we identified specif...
Summary: Tumor-initiating cells (TICs) contribute to drug resistance and tumor recurrence in cancers...
CONTEXT: Clinical management of testicular germ cell tumours (GCTs) is hampered by low sensitivity a...
Testicular cancer is an important disease with increasing incidence and a high burden of morbidity a...
Testicular cancer is the most common malignancy in men aged 14 - 44 years. In clinical management of...
Testicular germ cell tumors (TGCTs) are the leading form of solid cancer and death affecting males b...
Testicular cancer is the most common malignancy in men aged 14 - 44 years. In clinical management of...
microRNAs (miRs) are short non-coding RNA molecules (approximate to 21 nucleotides) involved in regu...
Testicular germ cell tumors (TGCTs) are the most frequent solid malignant tumors in men 20- 40 years...
BACKGROUND: Testicular germ cell tumors (TGCTs) respond well to cisplatin-based chemotherapy and sho...
Abstract Background Testicular germ cell tumors (TGCTs) respond well to cisplatin-based chemotherapy...
Testicular cancer (TC) is the most common solid tumor among young men. The prognosis of TC patients ...
Background: Ovarian cancer is the leading cause of death from gynecologic cancer in women worldwide....
BACKGROUND: Circulating microRNAs have clear potential for improving malignant germ-cell-tumor (MGCT...
Owing to advances in treatment paradigms across the last five decades, testicular cancer is now emin...
Background In addition to their involvement in mechanisms underlying cancer initiation and progressi...
Summary: Tumor-initiating cells (TICs) contribute to drug resistance and tumor recurrence in cancers...
CONTEXT: Clinical management of testicular germ cell tumours (GCTs) is hampered by low sensitivity a...
Testicular cancer is an important disease with increasing incidence and a high burden of morbidity a...
Testicular cancer is the most common malignancy in men aged 14 - 44 years. In clinical management of...
Testicular germ cell tumors (TGCTs) are the leading form of solid cancer and death affecting males b...
Testicular cancer is the most common malignancy in men aged 14 - 44 years. In clinical management of...
microRNAs (miRs) are short non-coding RNA molecules (approximate to 21 nucleotides) involved in regu...
Testicular germ cell tumors (TGCTs) are the most frequent solid malignant tumors in men 20- 40 years...
BACKGROUND: Testicular germ cell tumors (TGCTs) respond well to cisplatin-based chemotherapy and sho...
Abstract Background Testicular germ cell tumors (TGCTs) respond well to cisplatin-based chemotherapy...
Testicular cancer (TC) is the most common solid tumor among young men. The prognosis of TC patients ...
Background: Ovarian cancer is the leading cause of death from gynecologic cancer in women worldwide....
BACKGROUND: Circulating microRNAs have clear potential for improving malignant germ-cell-tumor (MGCT...
Owing to advances in treatment paradigms across the last five decades, testicular cancer is now emin...
Background In addition to their involvement in mechanisms underlying cancer initiation and progressi...
Summary: Tumor-initiating cells (TICs) contribute to drug resistance and tumor recurrence in cancers...
CONTEXT: Clinical management of testicular germ cell tumours (GCTs) is hampered by low sensitivity a...
Testicular cancer is an important disease with increasing incidence and a high burden of morbidity a...